Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
Metrics | Range | Conclusion |
---|---|---|
Selected LTM P/E Multiple | 147.1x - 162.6x | 154.9x |
Selected Fwd P/E Multiple | 44.8x - 49.6x | 47.2x |
Fair Value | ₩302,217 - ₩334,030 | ₩318,124 |
Upside | -35.9% - -29.2% | -32.5% |
Benchmarks | - | Full Ticker |
SK bioscience Co.,Ltd. | - | KOSE:A302440 |
Hugel, Inc. | - | KOSDAQ:A145020 |
Voronoi, Inc. | - | KOSDAQ:A310210 |
HLB Pep Co., Ltd. | - | KOSDAQ:A196300 |
SillaJen, Inc. | - | KOSDAQ:A215600 |
ALTEOGEN Inc. | - | KOSDAQ:A196170 |
- | - | - |
Select Price / LTM EPS Ratio | ||||||||
Benchmark Companies | ||||||||
A302440 | A145020 | A310210 | A196300 | A215600 | A196170 | |||
KOSE:A302440 | KOSDAQ:A145020 | KOSDAQ:A310210 | KOSDAQ:A196300 | KOSDAQ:A215600 | KOSDAQ:A196170 | |||
Historical Net Income Growth | ||||||||
5Y CAGR | NM- | 24.9% | NM- | NM- | NM- | NM- | ||
3Y CAGR | NM- | 34.0% | NM- | NM- | NM- | NM- | ||
Latest Twelve Months | -292.1% | 31.1% | -18.9% | 35.7% | -8.5% | 7452.0% | ||
Historical Net Income Profit Margin | ||||||||
5 Year Average Margin | 5.3% | 27.8% | -753.6% | -80.9% | -1535.4% | -12.0% | ||
Prior Fiscal Year | 6.0% | 29.1% | NA | -161.8% | -517.0% | -3.5% | ||
Latest Fiscal Year | -20.1% | 36.4% | NA | -109.1% | -675.5% | 60.5% | ||
Latest Twelve Months | -9.9% | 36.1% | -1280.4% | -109.3% | -396.3% | 59.7% | ||
Current Trading Multiples | ||||||||
EV / LTM EBITDA | -46.9x | 12.6x | -71.0x | -12.9x | -13.0x | 318.7x | ||
Price / LTM Sales | 6.9x | 7.6x | 918.7x | 13.9x | 66.2x | 159.5x | ||
LTM P/E Ratio | -70.3x | 21.2x | -71.8x | -12.7x | -16.7x | 267.4x | ||
Low | Mid | High | ||||||
Benchmark LTM P/E Ratio | -71.8x | -16.7x | 21.2x | |||||
Historical LTM P/E Ratio | -5675.7x | 327.2x | 1441.1x | |||||
Selected P/E Multiple | 147.1x | 154.9x | 162.6x | |||||
(x) LTM Net Income | 94,288 | 94,288 | 94,288 | |||||
(=) Equity Value | 13,870,720 | 14,600,758 | 15,330,796 | |||||
(/) Shares Outstanding | 53.5 | 53.5 | 53.5 | |||||
Implied Value Range | 259,352.67 | 273,002.81 | 286,652.95 | |||||
FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | ||||
Implied Value Range (Trading Cur) | 259,352.67 | 273,002.81 | 286,652.95 | 471,500.00 | ||||
Upside / (Downside) | -45.0% | -42.1% | -39.2% |
Equity Value | |||||||
Benchmark Companies | |||||||
(in millions) | A302440 | A145020 | A310210 | A196300 | A215600 | A196170 | |
Value of Common Equity | 3,706,861 | 3,082,570 | 3,077,750 | 67,191 | 421,296 | 25,216,801 | |
(/) Shares Outstanding | 78.4 | 10.8 | 18.0 | 9.3 | 138.1 | 53.5 | |
Implied Stock Price | 47,300.00 | 285,500.00 | 171,100.00 | 7,230.00 | 3,050.00 | 471,500.00 | |
FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
Implied Stock Price (Trading Cur) | 47,300.00 | 285,500.00 | 171,100.00 | 7,230.00 | 3,050.00 | 471,500.00 | |
Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |